362
Views
20
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Blueberry husks, rye bran and multi-strain probiotics affect the severity of colitis induced by dextran sulphate sodium

, , , , , & , PhD show all
Pages 1213-1225 | Received 25 Mar 2009, Published online: 19 Sep 2009

References

  • Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005; 206: 260–76
  • Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390–407
  • Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006; 12: 3–9
  • Reifen R, Nissenkorn A, Matas Z, Bujanover Y. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J Gastroenterol 2004; 39: 514–9
  • Kayo S, Ikura Y, Suekane T, Shirai N, Sugama Y, Ohsawa M, et al. Close association between activated platelets and neutrophils in the active phase of ulcerative colitis in humans. Inflamm Bowel Dis 2006; 12: 727–35
  • Simmonds NJ, Rampton DS. Inflammatory bowel disease: a radical view. Gut 1993; 34: 865–8
  • Yoshikawa T, Yamaguchi T, Yoshida N, Yamamoto H, Kitazumi S, Takahashi S, et al. Effect of Z-103 on TNB-induced colitis in rats. Digestion 1997; 58: 464–8
  • Ahnfelt-Ronne I, Nielsen OH, Christensen A, Langholz E, Binder V, Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 1990; 98: 1162–9
  • Buffinton GD, Doe WF. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radical Biol Med 1995; 19: 911–8
  • Kubes P, McCafferty DM. Nitric oxide and intestinal inflammation. Am J Med 2000; 109: 150–8
  • Permodo JJ, Cavaillon J-M, Huerre M, Ohayon H, Sansonetti PJ. Acute inflammation causes epithelial invasion and mucosal destruction in experimental Shigellosis. J Exp Med 2001; 180: 1307–19
  • Stadnyk AW, Dollard CD, Issekutz AC. Neutrophil migration stimulates epithelial cell cytokines during T. spiralis infection of the rat. J Leukoc Biol 2000; 68: 821–7
  • Olofsson T, Olsson I, Venge P, Elgefors B. Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol 1977; 18: 73–80
  • Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881–4
  • Isolauri E, Kirjavainen PV, Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation. Gut 2002; 50: 54–9
  • Russell WR, Labat A, Scobbie L, Duncan S. Availability of blueberry phenolics for microbial metabolism in the colon and the potential inflammatory implications. Mol Nutr Food Res 2007; 51: 726–31
  • Andreasen MF, Landbo A-K, Christensen LP, Hansen Å, Meyer AS. Antioxidant effects of phenolic rye (Secale cereale L.). Extracts, monomeric hydroxycinnamates, and ferulic acid dehydrodimers on human low-density lipoproteins. J Agric Food Chem 2001; 49: 4090–6
  • Medina V, Afonso JJ, Alvarez-Arguelles H, Hernández C, González F. Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. JPEN J Parenter Enteral Nutr 1998; 22: 14–7
  • Volker M. Dietary modification of the intestinal microbiota. Nutr Rev 2004; 62: 235–42
  • Lee HC, Jenner AM, Low CS, Lee YK. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol 2006; 157: 876–84
  • Heinonen M. Antioxidant activity and antimicrobial effect of berry phenolics: a Finnish perspective. Mol Nutr Food Res 2007; 51: 684–91
  • Kimura I, Nagahama S, Kawasaki M, Kataoka M, Sato M. Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (3). Folia Pharmacol Jpn 1996; 108: 259–66
  • Efthymiou C, Hansen CA. An antigenic analysis of Lactobacillus acidophilus. J Infect Dis 1962; 110: 258–67
  • Björck I, Nyman M, Pedersen B, Siljeström M, Asp N-G, Eggum B. Formation of enzyme resistant starch during autoclaving of wheat starch: studies in vitro and in vivo. J Cereal Sci 1987; 6: 159–72
  • Asp N-G, Johansson C-G, Hallmer H, Siljeström M. Rapid enzymatic assay of insoluble and soluble dietary fiber. J Agric Food Chem 1983; 31: 476–82
  • Theander O, Åman P, Westerlund E, Andersson R, Pettersson D. Total dietary fiber determined as neutral sugar residues, uronic acid residues, and Klason lignin (the Uppsala method): collaborative study. J AOAC Int 1995; 78: 1030–44
  • Richardson A, Calder A, Stewart C, Smith A. Simultaneous determination of volatile and non-volatile acidic fermentation products of anaerobes by capillary gas chromatography. Lett Applied Microbiol 1989; 9: 5–8
  • Murthy S, Murthy NS, Coppola D, Wood DL. The efficiency of BAY y 1015 in dextran sulfate model of mouse colitis. Inflamm Res 1997; 46: 224–33
  • Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulphates sodium experimental murine colitis. Lab Invest 1993; 69: 238–249
  • Khan I, Al-Awadi FM. Colonic muscle enhances the production of interleukin-1( messenger RNA in experimental colitis. Gut 1997; 40: 307–12
  • Osman N, Adawi D, Ahrné S, Jeppsson B, Molin G. Probiotic strains of Lactobacillus and Bifidobacerium affect the translocation and intestinal load of Enterobacteriaceae differently after D-galactosamine-induced liver injury. Microbiol Ecol Health Dis 2005; 17: 40–6
  • Håkansson Å, Stene C, Mihaescu A, Molin G, Ahrné S, Thorlacius H, et al. Rosehip and Lactobacillus plantarum DSM 9843 reduce ischemia/reperfusion injury in the mouse colon. Dig Dis Sci 2006; 51: 2094–101
  • Quednau M, Ahrné S, Peterson A, Molin G. Identification of clinically important Species of Enterococcus within 1 day with randomly amplified polymorphic DNA (RAPD). Curr Microbiol 1998; 36: 332–6
  • Brosius J, Palmer ML, Kennedy PJ, Noller HF. Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli. Proc Natl Acad Sci USA 1978; 75: 4801–5
  • Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403–10
  • Cole JR, Chai B, Marsh TL, Farris RJ, Wang Q, Kulam SA, et al. The Ribosomal Database Project (RDP-II): previewing and a new autoaligner that allows regular updates and the new prokaryotic taxonomy. Nucleic Acids Res 2003; 31: 442–3
  • Silk DB, Payne-James J. Inflammatory bowel disease: nutritional implications and treatment. Proc Nutr Soc 1989; 48: 355–61
  • Bistrian BR. Role of the systemic inflammatory response in the development of protein-energy malnutrition in inflammatory bowel disease. Nestle Nutr. Workshop Ser Clin Perform Programme. 1999; 2: 1–6
  • Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölisch UR, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53: 685–93
  • Zhang M, Liu B, Zhang Y, Wei H, Lei Y, Zhao L. Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroups in patients with ulcerative colitis. J Clin Microbiol 2007; 45: 496–500
  • Bränning C, Håkansson Å, Ahrné S, Jeppsson B, Molin G, Nyman M. Blueberry husks and multi-strain probiotics affect colonic fermentation and weight gain in healthy rats. Br J Nutr 2009; 101: 859–70
  • Barnich N, Darfeuille-Michau A. Adherent-invasive Escherichia coli and Crohn's disease. Curr Opin Gastroenterol 2007; 23: 16–20
  • Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2: 119–29
  • Simpson KW, Dogan B, Rishniw M, Goldstein RE, Klaessig S, McDonough PL, et al. Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun 2006; 74: 4778–92
  • Janeczko S, Atwater D, Bogel E, Greiter-Wilke A, Gerold A, Baumgart M, et al. The relationship of mucosal bacteria to duodenal histopathology, cytokine mRNA, and clinical disease activity in cats with inflammatory bowel disease. Vet Microbiol 2008; 128: 178–93
  • Egger B, Bajaj-Elliot M, McDonald TT, Inglin R, Eysselein VE, Buhler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000; 62: 240–8
  • Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995; 182: 1281–90
  • Nielsen OH, Kirman I, Rüdiger N, Hendel J, Vainer B. Up-regulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol 2003; 2: 180–5
  • Pena JA, Li SY, Wilson PH, Thibodeau SA, Szary AJ, Versalovic J. Genotypic and phenotypic studies of intestinal lactobacilli: species differences in mice with and without colitis. Appl Environ Microbiol 2004; 70: 558–68
  • Perdigon G, DeMacias MEN, Alvarez S, Oliver G, DeRuiz Holgado AAP. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun 1986; 53: 404–10
  • Vowinkel T, Kalogeris TJ, Mori M, Krieglstein CF, Granger DN. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig Dis Sci 2004; 49: 556–64
  • Hemme D, Raibaud P, Ducluzeau R, Galpin JV, Sicard P, Van Heijenoort J. Lactobacillus murinus n. sp., a new species of the autochthonous dominant flora of the digestive tract of rat and mouse. Ann Microbiol 1980; 131: 297–308
  • Molin G, Johansson M-L, Ståhl M, Ahrné S, Andersson R, Jeppsson B, et al. Systematics of the Lactobacillus population on rat intestinal mucosa with special reference to Lactobacillus reuteri. Antonie van Leeuwenhoek 1992; 61: 175–83
  • Sasaki E, Shimada T, Osawa R, Nishitani Y, Spring S, Lang E. Isolation of tannin-degrading bacteria isolated from feces of the Japanese large wood mouse, Apodemus speciosus, feeding on tannin-rich acorns. Syst Appl Microbiol 2005; 28: 358–65
  • Eade MN, Brooke BN. Portal bacteraemia in cases of ulcerative colitis submitted to colectomy. Lancet 1969; 1: 1008–9
  • Heddle RJ, Shearman DJC. Serum antibodies to Escherichia coli in subjects with ulcerative colitis. Clin Exp Immunol 1979; 38: 22–30
  • Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995; 36: 897–901
  • Pelissier MA, Muller C, Hill M, Morfin R. Protection against dextran sodium sulfate-induced colitis by dehydroepiandrosterone and 7alpha-hydroxy-dehydroepiandrosterone in the rat. Steroids 2006; 71: 240–8
  • Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365–76
  • Bradeley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Clin Dermatol 1982; 78: 206–9
  • Marnett LJ. Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002; 181–182: 219–22
  • Dal Sasso M, Culici M, Guffanti EE, Bianchi T, Fonti E, Braga PC. A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst. Pharmacology 2005; 74: 127–34
  • Stark G. Functional consequences of oxidative membrane damage. J Membr Biol 2005; 205: 1–16
  • Baskol G, Baskol M, Yurci A, Ozbakir O, Yucesoy M. Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis. Cell Biochem Funct 2006; 24: 283–6
  • Karppinen S, Kiiliäinen K, Liukkonen K, Forssell P, Poutanen K. Extraction and in vitro fermentation of rye bran fractions. J Cereal Sci 2001; 34: 269–78
  • Geier MS, Tenikoff D, Yazbeck R, McCaughan GW, Abbott CA, Howarth GS. Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase iv. J Cell Physiol 2005; 204: 687–92
  • Geier MS, Smith CL, Butler RN, Howarth GS. Small-intestinal manifestations of dextran sulphate sodium consumption in rats and assessment of the effects of Lactobacillus fermentum BR11. Dig Dis Sci 2009; 54(6)1222–8
  • Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T, et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 2008; 298: 463–72
  • Tedelind S, Westberg F, Kjerrulf M, Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 2007; 13: 2826–32
  • Vernia, P, Marcheggiano, A, Caprilli, R, Frieri, G, Corrao, G, Valpiani, , et al. Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 1995;9:309–13.
  • Hallert C, Björck I, Nyman M, Pousette A, Granno C, Svensson H. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis 2003; 9: 116–21
  • Stein RB, Hanauer SB. Comparative tolerability of treatments for inflammatory bowel disease. Drug Safe 2000; 23: 429–48

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.